Signet Healthcare Partners — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Ascendiapharmaascendiapharma.cominJun 2025
Ascendia Pharmaceutical Solutions is a contract development and manufacturing organization (CDMO) that provides formulation, nanotechnology, and manufacturing services for pharmaceutical and biological companies from pre-formulation through commercialization.
Advanced ManufacturingBiotechHealthtechMedical DevicesNorth Brunswick, US
Jingjun Huang(Executive Officer, Director)
BoardRobert Bloder(Director)Michael Bogda(Director)Shoufeng Li(Director)Theron Odlaug(Director)
Board seatJames Gale· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.